Develops gene therapies to cure retinal dystrophies
NightstaRx has raised €32M across 1 funding round from 1 investor, most recently a Series B round in Nov 2015. Based in London, UK; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series B | €32M |
| New Enterprise Associates |
| View deal → |
